TotalEnergies SE vs Zimmer Biomet Holdings Inc — how do they compare? TotalEnergies SE trades at $87.22 (market cap $196.06B), while Zimmer Biomet Holdings Inc trades at $97 (market cap $18.55B). The key difference: TotalEnergies SE is far larger — about 10.6× Zimmer Biomet Holdings Inc's market cap, and TotalEnergies SE pays the higher dividend (4.82%). Which is the better fit depends on your goals.
| TTE | ZBH | |
|---|---|---|
Market Cap | $196.06B | $18.55B |
Sector | Energy | Health |
52-Week High | $93.60 | $107.71 |
52-Week Low | $57.39 | $79.58 |
Enterprise Value | $227.06B | $25.61B |
Dividend Yield | 4.82% | 0.99% |
Signals from Pluang's Aura AI — not financial advice
TotalEnergies SE (TTE) trades at $87.96, up 2.48% today, with a bullish technical signal and strong analyst support. Recent earnings show mixed quarterly beats, while the company expands in renewables and gas projects. Valuation ratios like P/E of 11.01 and P/S of 0.98 appear attractive relative to sector peers.
The outlook is positive given strategic acquisitions and gas field developments, but risks include revenue declines and legal challenges. With a consensus price target of $94.00 and 57.58% buy ratings, the stock offers upside potential amid energy transition opportunities.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
TotalEnergies is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, it produced 1.5 million barrels of liquids and 7.2 billion cubic feet of natural gas per day. At year-end 2020, reserves stood at 12.1 billion barrels of oil equivalent, 45% of which are liquids. During 2021, it had LNG sales of 42 Mt. The company owns interests in refineries with capacity of nearly 1.8 million barrels a day, primarily in Europe, distributes refined products in 65 countries, and manufactures commodity and specialty chemicals. It also holds a 19% interest in Russian oil company Novatek. At year-end, its gross installed renewable power generation capacity was 10.3 GW.
Read more on TTE →Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →